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We describe a strategy for developing hydrophilic
chemical cocktails for tissue delipidation, decolor-
ing, refractive index (RI) matching, and decalcifica-
tion, based on comprehensive chemical profiling.
More than 1,600 chemicals were screened by a
high-throughput evaluation system for each chemi-
cal process. The chemical profiling revealed impor-
tant chemical factors: salt-free amine with high octa-
nol/water partition-coefficient (logP) for delipidation,
N-alkylimidazole for decoloring, aromatic amide for
RI matching, and protonation of phosphate ion for
decalcification. The strategic integration of optimal
chemical cocktails provided a series of CUBIC
(clear, unobstructed brain/body imaging cocktails
and computational analysis) protocols, which effi-
ciently clear mouse organs, mouse body including
bone, and even large primate and human tissues.
The updated CUBIC protocols are scalable and
reproducible, and they enable three-dimensional im-
aging of the mammalian body and large primate and
human tissues. This strategy represents a future
paradigm for the rational design of hydrophilic
clearing cocktails that can be used for large tissues.
INTRODUCTION
To examine an entire mammalian body as functional assemblies
of individual cells is an important goal in biology and medicine.
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The systematic identification of cellular properties in their phys-
iological context helps us understand the complex cellular net-
works in the body. To this end, three-dimensional (3D) imaging
techniques that use tissue clearing and are compatible with
various labeling techniques are promising approaches. The tis-
sue-clearing step is critical for determining the quality of the sub-
sequent acquired image and the feasibility of image processing.
Since tissue-clearing methods were first reported more than a
century ago (Spalteholz, 1914), the field has expanded dramati-
cally (Susaki and Ueda, 2016; Tainaka et al., 2016). Several scal-
able tissue-clearing protocols with high clearing performance
that can be used with 3D-imaging procedures were recently
developed. The perfusion-assisted agent release in situ-passive
clarity technique (PARS-PACT) protocol enables whole adult
mouse body clearing (Treweek et al., 2015; Yang et al., 2014).
The clear, unobstructed brain/body imaging cocktails and
computational analysis (CUBIC) protocol enables whole organ
and body imaging with single-cell resolution (Kubota et al.,
2017; Susaki et al., 2015; Tainaka et al., 2014). The system-
wide control of interaction time and kinetics of chemicals
(SWITCH) protocol achieves large (>1 cm3) tissue clearing,
including that of whole adult primate brain and large human tis-
sue samples (Murray et al., 2015). The ultimate DISCO (uDISCO)
protocol enables whole adult rat body imaging and the visualiza-
tion of high-resolution images of bone marrow in the entire
mouse body without chemical decalcification (Pan et al., 2016).
These protocols and related technologies have greatly advanced
the applicability of 3D imaging (Ando et al., 2014; Belle et al.,
2014, 2017; Doerr et al., 2017; Liebmann et al., 2016; Renier
et al., 2014, 2016). However, many clearing methods are still
empirical protocols based on serendipitously discovered effec-
tive chemicals and ad hoc chemical combinations. In contrast,
to achieve improved tissue-clearing techniques, it is important
to understand the effective functional groups and chemical
properties of each clearing step. Such comprehensive chemical
profiling would lead to rationally designed clearing cocktails.
Although organic solvents were systematically screened by
Sparteholz and his successors (Becker et al., 2012; Pan et al.,
2016), clearing cocktails based on hydrophilic chemicals are still
under development.
In this study, we applied a strategy for designing hydrophilic
chemical cocktails optimized for individual chemical parame-
ters. To achieve the scalable clearing of large primate and human
tissue samples and of mammalian bodies including bone tissue
in aqueous media, we considered a series of chemical pro-
cesses, including delipidation, decoloring, refractive index (RI)
matching, and decalcification. Using high-throughput evaluation
systems suitable for each chemical process, we comprehen-
sively screened >1,600 hydrophilic chemicals. Chemical
profiling of the screened chemicals revealed important chemical
factors: salt-free amine with high logP for delipidation, N-alkyli-
midazole for decoloring, aromatic amide for RI matching, and
protonation of phosphate ion for decalcification. Finally, by stra-
tegically integrating optimal chemical cocktails, we obtained a
series of updated CUBIC protocols that efficiently cleared
mouse organs, mouse body including bone, and large primate
tissue samples, including marmoset brain and human tissue
samples >10 cm3. The CUBIC-treated tissues were transparent
enough that almost all of the cells could be detected at the
whole-organ scale. In addition, a fluorescent protein (FP)-
compatible CUBIC protocol enabled the visualization of various
fluorescent labels.
RESULTS
Rational Chemical Profiles for Tissue Clearing Obtained
by Comprehensively Screening >1,600 CUBIC
Chemicals
To comprehensively screen chemicals for hydrophilic chemical-
based clearing methods, >1,600 commercially available chemi-
cal candidates were chosen based on their potential solubility
in aqueous media (Figure 1A; Table S1). If a chemical was suffi-
ciently soluble inwater, then a 10% (w/w) stock solutionwas pre-
pared in deionized water. These chemical solutions were then
subjected to a series of easy and high-throughput CUBIC assays
(for pH, fluorescent quenching of FPs, lipid solubility, decoloring,
RI matching, and decalcification) (Figures 1B–1F; Table S2).
After the first chemical screening, we narrowed down the candi-
dates by a second evaluation using real tissue (Table S2). The pH
of each stock solution was estimated by the colorimetric analysis
of pH-indicator paper (Figures S1A–S1C). To evaluate the
quenching effect of each chemical, recombinant EGFP and
Sirius were used as described previously (Figures 1F, S1D, and
S1E) (Susaki et al., 2014).
Delipidation and Decoloring
Qualitatively, the lipid solubility of a chemical is inversely
correlated with the turbidity of a fixed brain suspension treated
with the chemical (Susaki et al., 2014). Thus, we obtained lipid
solubility scores from the optical density 600 (OD600) of a
mixture of brain suspension and each 10% (w/w) chemical
solution (Figure 1B). We classified the chemicals into three
groups: detergents, salts, and other non-detergent and salt-
free chemicals. Anionic and non-ionic detergents with a
suitable logP (octanol-water partition coefficient) value of the
hydrophobic group exhibited significantly higher lipid solubil-
ity, while organic salts were less effective (Figures S2A–
S2C). The other water-soluble chemicals were subjected to
further functional chemical profiling. Aliphatic amines, amino
alcohols, and amino ethers were found to be the most effec-
tive functional groups for lipid solubility (Figure 2A). A basic
condition (pH >10) was significantly superior to an acidic
one (pH < 6) (Figure 2B). To determine the effective chemical
parameters for delipidation, we used a multivariate linear
regression model. We prepared a series of parameters con-
sisting of three classes, related to functional groups, solubility
(calculated by Hansen’s solubility parameters [Hansen, 2007]),
and structure and topology (Figure S1F). Figure S1G shows
examples of how we counted the functional groups. Our
model revealed logP to be the most influential property (Fig-
ure 2C). In actuality, the lipid solubility score of less polar
amines (logP R 2.0) was linearly correlated with their logP
(Figure 2D). Therefore, water-soluble, relatively hydrophobic,
and uncharged amine derivatives had the potential for high
lipid solubility. Next, we measured the residual phospholipid
and cholesterol contents of mouse brains treated with the
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chemicals and evaluated the relative transmittance of these
brains after RI matching with the modified ScaleCUBIC-2
(Figures 2E and S2D). The delipidation efficiency, especially
for the phospholipid content, was correlated with the final
tissue transparency, indicating that delipidation is essential
for thorough tissue clearing. Aliphatic amines exhibited a
much better delipidation efficiency than did amino alcohols
or detergents (Figure 2F). More important, the logP value of
these chemicals could predict the final transparency of the
chemically treated brain (Figure S2E). Therefore, the variability
within aliphatic amines and N-alcohols could be explained by
their logP value. It is likely that detergents were inferior to





Figure 1. Strategy for Screening >1,600 CUBIC Chemicals
(A) Experimental overview of the screening of >1,600 CUBIC chemicals. In the first in vitro screening, six chemical properties of potentially water-soluble CUBIC
chemicals were quantitatively evaluated. In the second evaluation, using real tissue samples, the candidate chemicals were narrowed down.
(B–F) Experimental scheme for the high-throughput chemical screening of delipidation (B), decoloring (C), RI measurement (D), decalcification (E), and FP
fluorescence measurement (F). A popular FP, EGFP, and a pH-insensitive FP, Sirius, were used. PFA, paraformaldehyde.
See also Figures S1 and S8 and Table S1.
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We established a high-throughput screening system for the
decoloring ability of chemicals bymeasuring the OD420 of the su-
pernatant obtained from a fixed blood suspension treated with
the chemical (Tainaka et al., 2014) (Figure 1C). Cationic deter-
gents tended to elute heme more efficiently, while organic salts
were significantly less active (Figures S2F and S2G). The pH de-
pendency of the decoloring was also similar to that of the lipid
solubility (Figure S2H). The functional chemical profiling of the
other water-soluble chemicals revealed chemical groups similar
to those identified in the lipid solubility assay (Figure 2G). We
noted that N-alkylimidazoles (1-ethylimidazole [CU#0938] and
1-(3-aminopropyl)imidazole [CU#0484]) were the most effective
decoloring chemicals. Next, we investigated how well these
chemicals decolored heme-rich mouse spleen by soaking
this tissue in the chemical solution and measuring the OD400 of




Figure 2. Comprehensive CUBIC Chemical Profiling for Delipidation and Decoloring
(A and B) Dependency of the lipid solubility score on the chemical functional group (A) and pH (B), compared with the alcohol group and pH 7–8, respectively.
(C) The variable importance projection (VIP) scores of two major partial least-squares (PLS) components for each variance.
(D) Scatterplot of the logP and lipid solubility score for water-soluble CUBIC chemicals. The logP of less polar amines (including aliphatic amines,N-alcohols, and
N-ethers with logPR 2.0) was correlated with their lipid solubility score.
(E) Scatterplot of the relative transmittance and phospholipid content of brain hemispheres of adult mice treated with highly lipid-soluble chemicals. Data are
means ± SDs (n = 2).
(F) Delipidation efficiency of the aliphatic amines, amino alcohol (N-alcohol), detergents, and others in (E).
(G) Dependency of the decoloring score on chemical functional groups compared with the alcohol group.
(H) Decoloring efficiency for adult mouse spleen of N-alkylimidazole (N-Alk-Imd), C-alkylimidazole (C-Alk-Imd), amine, pyridine, and cationic detergent (Cat Det).
(I) Representative chemical candidates for delipidation and/or decoloring. Box and whisker plots showing the 25th–75th percentile (boxes), 10th–90th percentile
(whiskers), median (vertical lines), and mean (cross). *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figures S1 and S2, Table S2, and the STAR Methods.


































































































































































































































































pH adjusted with imidazole
Halogen (n = 74)
Phosphate (n = 19)
Sulfur (n = 82)
Azole (n = 21)
Pyridine (n = 74)
Amide, Nitro (n = 118)
Amine (n = 361)
Aldehyde (n = 16)
Carboxylate (n = 153)
Ketone, Ester (n = 74)
Ether (n = 100)
Sugar (n = 45)
Alcohol (n = 287)
Phenyl (n = 140)
Alkene, Alkyn (n = 61)
All (n = 1025)









pH 12-13 (n = 106)
pH 11-12 (n = 41)
pH 10-11 (n = 45)
pH 9-10 (n = 50)
pH 8-9 (n = 58)
pH 7-8 (n = 83)
pH 6-7 (n = 202)
pH 5-6 (n = 207)
pH 4-5 (n = 56)
pH 3-4 (n = 42)
pH 2-3 (n = 70)
pH 1-2 (n = 60)
pH 0-1 (n = 12)







pH 13-14 (n = 51)
Histodenz



































































































































































Figure 3. Comprehensive CUBIC Chemical Profiling of RI Matching and Decalcification
(A) Dependency of RI on functional groups compared with the alcohol group.
(B) Scatterplot of 400-nm absorbance and RI. Less colored (OD400 <0.07) and high RI (RI >1.350) CUBIC chemicals were chosen for further screening.
(legend continued on next page)
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decoloring chemical among several chemical categories (Fig-
ure 2H). However, sinceN-alkylimidazole showed a low delipida-
tion efficiency, we further analyzed decoloring chemicals that
had a high delipidation efficiency. We applied the multivariate
linear regressionmodel to amine groups, and themodel revealed
the chain length to be the most influential parameter (Figure S2I).
Multiple polar groups (e.g., –NH2 and –OH) and a longer chain
length between the polar groups (C-ClengthR3) were associated
with efficient decoloring ability (Figure S2J).
Among the screened chemicals, we highlight the following four
chemicals: N-butyldiethanolamine and 1,3-bis(aminomethyl)
cyclohexane are a cost-effective, high-performance amino
alcohol and an aliphatic amine, respectively; 1,2-hexanediol is
an exceptional aliphatic diol that acts as a neutral delipidation
chemical; and 1-methylimidazole is especially effective for tissue
decoloring (Figure 2I).
RI Matching
To clarify whether the RI value of the medium itself is important
for the final transparency or whether specific chemical groups
are important for RI homogenization, we used a non-biased
approach to determine the best RI-matched chemicals. To
develop an alternative high-RI medium based on hydrophilic
chemicals, we selected candidate chemicals that had high water
solubility and a high RI value per unit weight, because the RI
value of aqueousmedium increases according to the solute con-
centration. Chemical profiling of the RI values of 10% (w/w)
chemical solutions with an Abbe refractometer (Figure 1D) re-
vealed that aromatic groups (phenyl, pyridine, and azole groups)
exhibited higher RI values among the chemical groups (Fig-
ure 3A). We then chose candidate chemicals with high RI values
(R1.350) and low absorbance (OD400 <0.07) to avoid incoming
light absorption by the medium itself (Figure 3B). We chose 21
extremely water-soluble RI-matching candidates, including
Histodenz (soluble in water at 60–70 wt%; Sigma-Aldrich),
whose RIs ranged from 1.47 to 1.52. To examine the clearing
performance of these chemicals qualitatively, the OD600 of small
pieces of chemically treated mouse lung was measured
(Figure 3C). The RI values of the mounting medium showed no
correlation with the tissue transparency, suggesting that the
clearing performance does not depend solely on the RI value
of the medium but does reflect some chemical properties of
the constituent. We further applied the multivariate linear regres-
sion model to this result. The amide group showed a significantly
higher clearing performance than the other chemical groups
(Figures 3D, 3E, and S2K). Finally, we introduced antipyrine
and CU#1283 (N-methylnicotinamide) as RI-matching chemicals
(Figure 3J, top). N-Methylnicotinamide had the highest clearing
performance among the candidates. In addition to its high
clearing performance, antipyrine avoided tissue shrinkage,
even with a dense solution, because this chemical causes tissue
swelling (Murakami et al., 2018).
Decalcification
Inorganic bone mineral mostly consists of carbonated hydroxy-
apatite (HAp). Thus, we developed anHAp-based screening sys-
tem to identify potent decalcification chemicals by measuring
the OD600 of a chemically treated HAp suspension (Figure 1E).
The OD600 of HAp suspensions was linearly correlated with the
HAp concentration below 10 mg/mL (Figure S2L). Decalcifica-
tion was strongly promoted by an acidic condition, especially
below pH 2.0 (Figure 3F). Because phosphate ion has a pKa1
value of 2.12 (Weast, 1983), the facilitated decalcification under
acidic conditions may have been associated with an equilibrium
shift in the phosphate ion. Since acid-based decalcification was
incompatible with many of the other tissue-clearing steps, we
sought other decalcifying chemicals that would act in neutral
medium. We found that the decalcification efficiency of a 10 wt
% EDTA-Na solution markedly decreased over pH 8.0 (Fig-
ure 3G). Although this result apparently contradicts the pH de-
pendency of the stability constant of EDTA for the calcium ion
(Harris, 2011), an unexpected pH dependency was already re-
ported for both decalcification and demineralization by EDTA (Ki-
viranta et al., 1980; Serper and Calt, 2002). This may also reflect
the equilibrium shift of the phosphate ion because of its pKa2
value of 7.21. It is also noteworthy that a 10 wt% EDTA solution
neutralized with N-butyldiethanolamine exhibited significantly
higher decalcification efficiency at pH 8.0 than did EDTA-Na (Fig-
ure 3G), implying that decalcification would be greatly facilitated
by neutralization with an organic base instead of an inorganic
base (NaOH). Therefore, we screened EDTA-related acids and
N-butyldiethanolamine-related organic bases among the listed
chemicals. While EDTA-related calcium chelators including
CU#0065 (trans-1,2-diaminocyclohexane-N,N,N0,N0-tetraacetic
acid monohydrate [CyDTA]) and CU#0624 (1,2-diaminopro-
pane-N,N,N’,N’-tetraacetic acid [PDTA]) were the most effective
(C) Scatterplot of the RI value of concentrated solutions of 22 candidate chemicals and the OD600 of small pieces of mouse lung treated with those chemicals.
Data are means ± SDs (n = 2).
(D) VIP scores of two major components for each variance.
(E) The 22 chemicals in (C) were divided into three groups: amides, amidines, and others, and theOD600 of lungs treatedwith these groupswere compared. Amide
and amidine groups are shown in red dashed-line boxes at right.
(F) Dependency of relative decalcification score on pH compared with pH 7–8.
(G) pH dependence of OD600 of chemically treated HAp suspension. Data are means ± SDs (n = 3). N-butyldiethanolamine (CU#0414) 10 wt% titrated with EDTA
or HCl and EDTA 10 wt% titrated with CU#0414 or NaOH were used.
(H) Relative decalcification scores of EDTA-based cocktails (pH 7–8) neutralized with various counter-bases including heterocyclic amines without primary amine
(Hetcyc amine w/o 1 amine), secondary and tertiary amines and quaternary ammoniums (2–4 amine), and other amines including primary amine (1 amine).
(I) Relative decalcification score of EDTA derivatives. Data are means ± SDs (n = 3). Chemicals are presented in descending order of logK. Chemical ID is a typical
abbreviation or vendor catalog number. The top three chemicals shared a common EDTA structure (red).
(J) Chemical candidates for high RI matching medium and decalcification cocktails consisting of EDTA and imidazole (CU#1352). Box and whisker plots show
25th–75th percentiles (boxes), 10th–90th percentiles (whiskers), median (horizontal lines), and mean (cross). *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figures S1 and S2, Table S2, and the STAR Methods.
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10 wt% N-butyldiethanolamine (CU#0414), 10 wt% Triton X-100
45 wt% antipyrine (CU#0640), 30 wt% nicotinamide (CU#0855), optionally pH 8-9
adjusted by N-butyldiethanolamine (CU#0414)
CUBIC-HL
45 wt% antipyrine (CU#0640), 30 wt% N-methylnicotinamide (CU#1283), optionally pH 8-9
adjusted by N-butyldiethanolamine (CU#0414)
5 wt% 1-methylimidazole, 10 wt% N-butyldiethanolamine (CU#0414), 5 wt% Triton X-100
10 wt% EDTA, 15 wt% imidazole (CU#1352)
10 wt% 1,3-bis(aminomethyl)cyclohexane (CU#0070), 10 wt% sodium dodecylbenzenesulfonate
(CU#0631), pH 12.0 adjusted by p-toluenesulfonic acid
Role
Delipidation and decolorization
RI matching, more cost effective than CUBIC-RA
RI matching, kinder to FP than CUBIC-R
Delipidation and rapid decolorization
Decalcification
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(legend on next page)
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decalcification acids, heterocyclic amines without a primary
amine were found to be the optimal organic base (Figures S2M
and 3H). EDTA-related chemicals (e.g., EDTA, CyDTA, and
PDTA) were still superior to other chelators, even to 1,4,7,10-tet-
raazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and
EGTA, which have higher stability constants for calcium ion
(logK) than EDTA (Figure 3I), suggesting that the specific chem-
ical nature of EDTA may play an important role in an organic
base-assisted decalcification. Collectively, the combined cock-
tail of EDTA and imidazole appeared to be the optimal decalcifi-
cation solution (Figure 3J, bottom).
Rapid and Scalable Tissue Clearing by Updated CUBIC
Protocols Combining Various CUBIC Cocktails
The above experiments independently identified a series of
CUBIC chemicals with high performance for delipidation, de-
coloring, RI matching, and decalcification. Because the requi-
site chemical properties for tissue clearing differ depending
on the nature of the sample (e.g., lipid content, FP expression,
existence of bone tissue), we sought to develop representative
CUBIC cocktails that cover existing clearing demands. We
began by developing two kinds of delipidation and decoloring
cocktails, representing upgrades of ScaleCUBIC-1: one for
FP-compatible rapid delipidation and decoloring (CUBIC-L)
and another for very rapid delipidation and decoloring
(CUBIC-HL). According to our screening results, N-butyldietha-
nolamine and 1,3-bis(aminomethyl)cyclohexane were chosen
for the main components of CUBIC-L and CUBIC-HL, respec-
tively, because they had both high lipid solubility and decoloring
scores. The combinatorial evaluation of detergents was per-
formed using biological tissues. Since it is difficult to distinguish
the clearing performance of individual cocktails under a long
incubation time, we applied N-butyldiethanolamine-based
cocktails to mouse brain and kidney and to human brain with
a brief incubation (Figures 4A and S3A). The cocktail of N-butyl-
diethanolamine and Triton X-100 (termed CUBIC-L) exhibited
the highest clearing ability for all of the specimens. The
delipidation efficiency of all of the tested solutions was compa-
rable in mouse brain and kidney, while anionic detergent-based
cocktails (SDS, CU#0631 [sodium dodecylbenzenesulfonate],
and CU#0865 [sodium nonanoate]) exhibited slightly higher
efficiencies than other solutions in human brain (Figure 4B).
Notably, the tissue transparency of CUBIC-L was superior to
that of other anionic detergent-based cocktails.
Sodium dodecylbenzenesulfonate (CU#0631) was an optimal
cocktail for clearing human brain and kidney among the 1,3-bi-
s(aminomethyl)cyclohexane-based cocktails (Figures 4C, 4D,
and S3H). The cocktail of 1,3-bis(aminomethyl)cyclohexane
and sodium dodecylbenzenesulfonate (CU#0631) (CUBIC-HL)
achieved almost full delipidation. Next, we sought to optimize
the RI-matching medium, an upgrade of ScaleCUBIC-2, based
on N-methylnicotinamide (CU#1283). Combinatorial experi-
ments revealed that the cocktails of N-methylnicotinamide
(CU#1283)-Histodenz and CU#1283-antipyrine showed much
higher clearing performance than the single chemical
solutions and other N-methylnicotinamide (CU#1283)-based
cocktails (Figures 4E and S3F). In terms of cost efficiency, we
chose the cocktail containing 30 wt% N-methylnicotinamide
(CU#1283) and 45 wt% antipyrine as the RI-matching
medium (CUBIC-RA). The even less expensive nicotinamide
(CU#0855), a demethylated derivative of CU#1283, served as
a convenient surrogate for N-methylnicotinamide (CU#1283)
in combination with antipyrine; this cocktail was named
CUBIC-R (Figure S3B).
We previously reported that a transient perfusion of
ScaleCUBIC-1 effectively cleared whole-body samples (Susaki
et al., 2015; Tainaka et al., 2014). For this purpose, we introduced
an optional CUBIC-L-based perfusion cocktail that included the
decoloring-effective 1-methylimidazole, named CUBIC-P. To
achieve efficient decalcification compatible with whole-body
clearing, we chose the cocktail of 10 wt% EDTA and 15 wt%
imidazole, named CUBIC-B. The proposed CUBIC cocktails
except CUBIC-HL sufficiently preserved the fluorescent signal
of mCherry (Figure 4F). CUBIC-RA is more feasible for various
FPs such as EGFP and yellow fluorescent protein (YFP) than
CUBIC-R (Figure S3E). These series of CUBIC cocktails are sum-
marized in Figure 4G (original CUBIC protocol in Figure S3G),
and four CUBIC protocols sequentially combining these cock-
tails are summarized in Figure 4H. By applying the protocols to
a variety of tissue samples, including large human tissues, we
demonstrated the effects of the updated CUBIC protocols
(Figures 4I–4N, S3C, S3D, and S3I).
Figure 4. Combinatorial Screening of CUBIC Chemicals for Rapid and Scalable Tissue-Clearing CUBIC Protocols
(A) Combinatorial screening of delipidation chemicals compatible with FP. CU#0414 was mixed with various detergents. Mouse brain hemispheres, kidneys, and
human brain blocks were delipidated with individual chemical cocktails and were then immersed in CUBIC-R.
(B) Phospholipid content of the tested biological tissues treated with CU#0414-based delipidation cocktails (n = 3).
(C) Combinatorial screening of delipidation chemicals for human brain and kidney blocks. 1,3-bis(aminomethyl)cyclohexane (CU#0070) was mixed with various
detergents.
(D) Phospholipid content of human brain blocks treated with CU#0070-based delipidation cocktails. The CU#0070-CU#1455 cocktail precipitated (n = 3).
(E) Combinatorial screening of RI matching reagents. Delipidated adult (8-week-old) mouse lungs were immersed in highly concentrated chemical cocktails. RI of
the mixtures is shown in blue.
(F) Time course of fluorescent signals from mCherry with each CUBIC cocktail (n = 3).
(G and H) Chemical components in CUBIC cocktails (G), and CUBIC protocols using serial treatments with CUBIC cocktails (H).
(I) Clearing performance of CUBIC protocol I for adult (6-week-old) mouse brain and kidney.
(J–L) Clearing performance of CUBIC protocol II for adult (8-week-old) mouse leg (J), P7 mouse head and body (K), and adult (8-week-old) mouse spinal cord
(L4–L6) (L). Grids were visible through hard bone tissue (red arrows, K).
(M) Clearing performance of CUBIC protocol III for human heart and kidney blocks.
(N) Clearing performance of CUBIC protocol IV for human brain block.
Scale bars indicate 4 mm. Data are means ± SDs. See also Figure S3.
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Inspection of the Tissue Integrity of CUBIC-Treated
Organs
To demonstrate how the CUBIC protocols could outperform
other clearing methods, we compared CUBIC protocol I with
previously reported clearing methods. The final clearing perfor-
mance of the CUBIC protocols was significantly better than
that of other protocols (Figure S4). The updated CUBIC protocol
also improved the imaging quality at deeper regions of the sam-
ple (Figure 5A). Since tissue clearing is often accompanied by
macroscale tissue deformation, we also examined the effect of
clearing on the brain macroshape. Because the final morphology
of tissues was influenced by the pH of CUBIC-R, we tested both
neutral and weakly basic CUBIC-Rs. The neutral CUBIC-R
showed little deformation, while the weakly basic CUBIC-R ex-
hibited swelling (Figure 5B). In addition, a cleared mouse brain
(CUBIC protocol I) showed preserved subcellular microstruc-
tures (Figure 5C). To evaluate protein loss during the clearing
process, we quantified the amount of residual protein after a
4-day delipidation using human brain tissue. Most of the endog-
enous protein was retained in the brain after CUBIC delipidation,
even using the harshest CUBIC-HL protocol (Figure S4D). We
also tested the antigenicity of delipidated mouse brain by immu-
nohistochemistry using anti-glial fibrillary acidic protein (GFAP)
and anti-NeuN antibodies and found that the antigenicity was
preserved after a 4-day CUBIC-HL treatment (Figure 5D).
In addition, using various antibodies on delipidated human
brain, we observed that the antigenicity remained unaltered after
a 9-day CUBIC-L treatment (Figure 5E). We further demon-
strated the applicability of the protocols for 3D staining using
lectin and an anti-smooth muscle actin (SMA) antibody on
CUBIC-L delipidated human brain (Figure 5F). These findings
indicated that the proposed protocols largely retain the amount
and antigenicity of the proteins. We also applied our CUBIC
protocols to comprehensive cell analysis at the whole-organ
scale (Figure S5). The application of the CUBIC protocol I
revealed comprehensive segmentation of the glomeruli in a
mouse kidney (Figures S5A–S5E) andwhole-organ cell detection
in the left medial lobe of the liver and left lung of amouse (Figures
S5F–S5M)
Scalable Imaging of Mouse Whole Body, Including the
Inside of Bone, and Large Human Organ Blocks by
CUBIC Protocols
To perform exhaustive whole-body imaging, we applied
CUBIC protocol II to render transparent the whole body of a
P7 mouse and stained it with nuclear-staining dye (Figure 6A;
Video S1). The volume rendered whole-body image showed
strong fluorescence inside bones, as seen in the densely
concentrated cells in the bone marrow (Figure 6B). CUBIC
protocol II enabled brain and spine imaging at single-cell res-
olution in the skull and backbone (Figures 6C, 6D, S6A, and
S6B). The imaging was even possible with adult mouse head
and spine (Figures S6C–S6H). Next, we applied this protocol
to metastatic bone tumors in the leg of an MDA-231-D-in-
jected mouse (Figures 6E–6H and S6I) and observed the infil-
tration of metastatic cancer cells from bone tissue to the adja-
cent soft tissues. The metastatic bone tumors were even
visible through skull (Figures S6J and S6K)
To examine the scalability of the CUBIC protocols, we applied
CUBIC protocol III to large human tissue blocks; a large chunk of
dissected human lung (approximately 43.4 3 16.0 3 26.4 mm3;
Figure S6L; Video S2), dissected human kidneys (Figure S6N),
and a dissected human liver. Using light-sheet fluorescence mi-
croscopy (LSFM), multidirectional imaging was performed to ac-
quire autofluorescence images throughout the blocks. We
confirmed that the fluorescent signal was sufficient for imaging
even deep within the blocks (Figures 6I, S6M, and S6O–S6Q).
To examine the feasibility of volumetric imaging of human kidney
at single-cell resolution, we visualized the 3D structure of the
glomerulus after nuclear staining. Confocal imaging of the highly
cleared tissue enabled the identification and segmentation of
glomeruli in the magnified view (Figure 6J) and even the compre-
hensive detection of glomerular cells in the magnified view (Fig-
ures 6K and 6L).
We next performed the whole-brain imaging of an adult
marmoset. The brain of a 1-year-old malemarmoset was cleared
using a modified CUBIC protocol I with propidium iodide (PI)
staining, resulting in a cleared PI-stained brain without apparent
morphological distortion (Figure S6R). The whole-brain images
were acquired with LSFM and subjected to 3D image reconstitu-
tion to generate a volume-rendered image (Figures 6M and 6N;
Video S3). Individual cells were distinguishable even in the
deep regions of the brain (Figure 6O).
Multiple Visualization of Transgenically Labeled FPs in
Mouse Brain
Simple immersion-based CUBIC protocols should be appli-
cable and highly reproducible for tissue clearing without the
significant quenching of FPs. We next used CUBIC protocol
I combined with the visualization of a series of fluorescently
labeled mouse samples. We prepared mouse brains with a
wide variety of genetically encoded FPs (Thy1-YFP [Feng
et al., 2000], P(CAG)-EGFP [Okabe et al., 1997], Drd1-mVenus
[Nagai et al., 2016], Th-EGFP [Matsushita et al., 2002], Mcl1-
YFP [Mlc1-tTA (Tanaka et al., 2010)::tetO-YC (Kanemaru
et al., 2014)], Plp-YFP [Plp-tTA {Inamura et al., 2012}::tetO-
ChR2EYFP {Tanaka et al., 2012}], and Htr5b-YFP [Htr5b-tTA
{Tanaka et al., 2012}::tetO-YC]). The brain samples were sub-
jected to CUBIC protocol I, with CUBIC-RA as an RI matching
reagent to preserve the FP signals. All of the brains were
treated with a nuclear staining dye (RedDot2) for registration,
and images were acquired with LSFM, resulting in two volu-
metric images (one for the nuclear stain and the other for
the FP signal) for each brain. We registered the nuclear images
to that of a reference brain, and directly compared the FP
signals by overlaying their registered images, as we reported
previously (Susaki et al., 2014, 2015), thus achieving virtual
multiplex whole-brain imaging (Figures 7A, S7A, and S7B).
The overlaid image made it possible to compare the global
distribution of pyramidal neurons (Thy1-YFP), astrocytes
(Mlc1-YFP), oligodendrocytes (Plp-YFP), dopaminergic neu-
rons (Th-EGFP), serotonin receptor 5B (Htr5b-YFP), and dopa-
mine receptor D1 (Drd1-mVenus) at the whole-brain scale (Fig-
ures 7B and S7C; Video S4). This systematic approach to
analyzing the global distribution of expressed genes enabled
us to investigate the distribution of neural subtypes in the
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Figure 5. Tissue Integrity of CUBIC-Treated Organs
(A) LSFM images of nucleus-stained 8-week-old brain, lung,
and left medial lobe of the liver after CUBIC protocol 0 and
CUBIC protocol I. To compare the image qualities fairly,
imaging was performed only from one side of the tissue. x
indicates the illumination direction and z indicates the
detection direction of the LSFM. For brain, the hypothalamic
nuclei of paraventricular nuclei (PVN) are visualized in the
insets. The scales for CUBIC protocols 0 and I were slight-
ly adjusted to correct for shrinkage caused by CUBIC pro-
tocol 0.
(B) Deformation analysis of cleared 8-week-oldmouse brains
using CUBIC protocol I. The cleared brains were registered
to a standard brain, and then the deformation fields were
visualized on the projection images of the brains. In the RI-
matching step, neutral CUBIC-R (without #0414; middle) and
basic CUBIC-R (pH 8–9 adjusted with CU#0414; bottom)
were applied; see also STAR Methods for details.
(C) Subcellular imaging of a 6-month-old Thy1-YFP mouse
brain after CUBIC protocol I. A cellular view (left) and a
magnified view (right) are shown. A representative spine is
indicated by a red arrow (right).
(D) Immunohistochemistry of an 8-week-old mouse brain
after a 4-day CUBIC-HL treatment. Anti-GFAP (top) and anti-
NeuN (bottom) antibodies were used.
(E) H&E (HE) staining (top left) and immunohistochemistry of
human brain after CUBIC protocol IV. Antibodies for glial
fibrillary acidic protein (GFAP), ionized calcium-binding
adaptor molecule 1 (Iba-1), neurofilament (NF), myelin basic
protein (MBP), and laminin were examined.
(F) Visualization of vascular structures in thick slices of a
human brain. Lectin (for 0.4-mm-thick brain slice; left) and
anti-a-SMA antibody (for 1.5-mm-thick slice; right) were
applied. The 3D volumetric images were obtained with
LSFM.
See also Figures S4 and S5.
Cell Reports 24, 2196–2210, August 21, 2018 2205
cerebral cortical layers (Figures 7C, 7D, and S7D). In utero
electroporation is another method for introducing an exoge-
nous gene. We unilaterally introduced P(CAG)::mRFP (mono-
meric red fluorescent protein) into mouse brain by in utero
electroporation (Hayashi-Takagi et al., 2015) and analyzed
the spatial distribution of the induced genes by virtual multi-
plex whole-brain imaging; this demonstrated that the mRFPs
were mainly expressed into layer 4 (Figures 7E–7G). Further-
more, FP expressed in metastatic tumor cells (MDA-231-D
cancer cells expressing mCherry) was also clearly visible using
our CUBIC protocol I, allowing the morphological analysis of
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Figure 6. Scalable Imaging of Mouse Whole Body, Including Bone, and of Large Human Tissue Blocks with Single-Cell Resolution
(A and B) Volume-rendered images of whole mouse body (P7) stained with nuclear-staining dye. Ventral-dorsal whole-body view (A) andmagnified view of left leg
(B). Inset of (B), sectional view of the leg. CUBIC protocol II was applied.
(C and D) Confocal images of the brain inside the skull in a sagittal plane (C) and of the spine in a sagittal plane (D). Yellow arrows indicate bone tissues.
(E) Bioluminescence image of an MDA-231-D-injected immunodeficient BALB/c-nu/nu mouse.
(F) Volume-rendered image of the right leg of themouse in (E). Magenta and cyan indicatemetastasized cancer cells (mCherry) and nuclei (RedDot2), respectively.
(G and H) Frontal (G, left), orthogonal (G, right), and magnified (H) views of (F). For (H), the segmented metastatic colony was visualized. For (F)–(H), CUBIC
protocol II was applied.
(I) Volume-rendered image of the autofluorescence in a dissected human lung. CUBIC protocol III was applied.
(J) Volume-rendered image of nuclear-stained human kidney. Several glomeruli were segmented and are shown at right. CUBIC protocol III was applied.
(K and L) Confocal imaging of a single glomerulus in the human kidney. Volume-rendered image (K), sectional image (L, top) and magnified single-cell-resolution
view of the sectional image (L, bottom).
(M–O) Adult marmoset brain stained for nuclei. Volume-rendered image of whole brain (M), sectional views (N), and highly resolved images (O). All images ac-
quired with LSFM. Modified CUBIC protocol I was applied (STAR Methods).
See also Figure S6.
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DISCUSSION
Here, by applying comprehensive chemical profiling for delipida-
tion, decoloring, RI matching, and decalcification, we designed a
set of chemical tools for tissue clearing. Organic salts had poor
efficiencies for delipidation and decoloring (Figures S2A and
S2F). The undesirable effect of ionic charge in these steps was
probably related to its effect on the molecular flux between a tis-
sue and the external medium (Hama et al., 2011; Hou et al.,
2015). Deionization by an osmotic-pressure gradient is a
straightforward way to increase molecular flux; therefore, non-
ionic cocktails that promoted molecular flux were advantageous
in these steps. Detergents also had unexpectedly poor effi-
ciencies for the delipidation and decoloring of tissue samples,
given their high scores in the in vitro assay (Figures 2F, 2H,
S2A, and S2F). Tissue delipidation and decoloring using deter-
gents is often achieved by combining them with other tissue-
permeable chemicals (Hama et al., 2015; Susaki et al., 2014) or
with chemophysical assistance (Chung et al., 2013; Murray
et al., 2015; Tainaka et al., 2014; Yang et al., 2014). Detergents
generally show slow tissue-permeation kinetics as a result of
large micelle formation, which could explain their poor efficiency
in tissue. In contrast, amine derivatives with higher logP values
are expected to be more cell permeable and more miscible
with hydrophobic lipids. Among the current decoloring reagents,
N-alkylimidazole showed the highest decoloring ability. N-Alkyli-
midazole facilitates heme elution under basic conditions by
competing with histidine for binding to the heme iron center.
In the RI-matching step, an external medium with a high RI
value similar to that of endogenous proteins (RIR1.45) replaces
the low-RI water (RI = 1.33) inside tissue. The final tissue trans-
parency improves as the RI value of the medium increases (up
to 1.52) under a given chemical composition (Kubota et al.,
2017). Organic solvent-based RI media have high RI values
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Figure 7. Multiple Visualization of Transgenically Labeled FPs in Mammalian Brains and Scalable Imaging of Brains with Single-Cell
Resolution
(A–D) Virtual multiplex images of FP-expressing mouse brains registered to a standard brain. Overlaid images of seven different FPs (horizontal view; 300-mm-
thick projection) (A). Individual expression patterns andmerged images in magnified views of the indicated region of (A) (B). Overlaid images of three different FPs
(coronal view; 300-mm-thick projection) (C) and magnified view of the indicated region of (C) (D). Cortical layer structures are indicated in (D).
(E and F) Multiplex images of mouse brain labeled with EP-induced mRFP overlaid with Thy1 and nuclear images. Volumetric image (E) and coronal view of the
300-mm-thick projection in (E) and (F).
(G) Subcellular resolution imaging of mRFP-expressing cells by confocal microscopy.
(H) Metastasized colonies of MDA-231-D cells expressing mCherry (MS mCherry) in mouse brain; volumetric image overlaid with nuclear image. Inset shows
segmented volumes of cancer metastasis.
For (A)–(H), CUBIC protocol I was applied. See also Figure S7 and STAR Methods.
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(e.g., benzyl alcohol/benzyl benzoate [BABB], 1.56; dibenzyl
ether [DBE], 1.56). Our chemical profiling demonstrated that ar-
omatic groups have high RI values because of their high electron
density (Figure 3A). Thus, an aromatic derivative is likely to be a
suitable constituent of RI media. In addition, the tissue clearing
performance in a variety of RI media demonstrated that the final
transparency was determined not only by the RI value but also by
the chemical nature of the components of the RI medium (Fig-
ures 3C and 3E). Among the clearing protocols, sugar-based
RI medium (e.g., see deep brain [SeeDB, Ke et al., 2013] and
ScaleCUBIC-2) elicits moderate clearing compared with RI me-
dia consisting of contrast reagents (e.g., CLARITY, refractive in-
dex matching solution [RIMS], SeeDB2 [Ke et al., 2016], and
SWITCH). The effectiveness of antipyrine and nicotinamide in
our screen indicated that the high clearing efficiency of contrast
reagents is derived from their aromatic amide group. Since high-
ly delipidated tissues are regarded as protein-based biomate-
rials (Murakami et al., 2018), it is plausible that hydrophilic aro-
matic amides contributed to RI homogenization because of
their efficient solvation of protein backbone amides. A future
strategy for improving RI media will be to explore chemical com-
binations that promote the solvation of the major proteins in
tissues.
Our updated protocols have a few potential limitations. Since
both of the delipidation cocktails are alkaline-buffered solutions,
almost all of theendogenousRNAwouldbedegraded.Toperform
RNAprofiling, a 1,2-hexanediol-baseddelipidationcocktail needs
to be developed. In addition, much of the presynaptic and post-
synaptic fabric is reported todisappearwith thoroughdelipidation
protocols such as 3D imaging of solvent-cleared organs
(3DISCO), PACT, and the original ScaleCUBIC (Hama et al.,
2015). Therefore, our protocols would be not suitable for the
observation of these structures by electron microscopy. Further-
more, while our decoloring reagents are effective for bleaching
porphyrine-related pigments such asmyoglobin and cytochrome
c, they are unlikely to affectmelanin,which is formedby the oxida-
tive polymerization of amino acids (Sealy et al., 1980). Another de-
coloring strategy is needed tobleachsuchpolymerizedpigments.
In summary, we applied comprehensive chemical profiling as
a rational design strategy for obtaining purposeful clearing cock-
tails. A visual guide for this design strategy is shown in Figure S8.
The application of these protocols should contribute to a rich va-
riety of studies, including the prospective atlas of human cells.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
GFAP Sigma-Aldrich Cat#C9205; AB_476889
NeuN Millipore Cat#MAB377; AB_2149209
Donkey anti-mouse IgG Thremo Fisher Scientific Cat#A21203; AB_2535789
GFAP Dako Cat#Z0334; AB_10013382
Iba1 Wako Cat#019-19741; AB_839504
Laminin Dako Cat#Z0097; AB_10013382
MBP Dako Cat#A0623; AB_2650566
NF Monosan Cat#MON3004; AB_2314914
a-SMA Novus Biological Cat#IC1420R
Lectin Vector Laboratories Cat#RL-1062
Biological Samples
Horse blood Kohjin-Bio Cat#12070110
Chemicals, Peptides, and Recombinant Proteins
Pentobarbital Nacalai Tesque Cat#02095-04
Paraformaldehyde Nacalai Tesque Cat#02890-45
Quadrol Tokyo Chemical Industry Cat#T0781
Triethanolamine Wako Pure Chemical industries Cat#145-05605
Triton X-100 Nacalai Tesque Cat#12967-45
Urea Nacalai Tesque Cat#35904-45
Sucrose Nacalai Tesque Cat#30403-55
SDS Nacalai Tesque Cat#31606-75
Histodenz Sigma-Aldrich Cat#D2158
N-Butyldiethanolamine (CU#0414) Tokyo Chemical Industry Cat#B0725
1,3-Bis(aminomethyl)cyclohexane (cis- and
trans- mixture) (CU#0070)
Tokyo Chemical Industry Cat#B1005
1-Methylimidazole Tokyo Chemical Industry Cat#M0508
Antipyrine (CU#0640) Tokyo Chemical Industry Cat#D1876
N-Methylnicotinamide (CU#1283) Tokyo Chemical Industry Cat#M0374
Nicotinamide (CU#0855) Tokyo Chemical Industry Cat#N0078
EDTA Tokyo Chemical Industry Cat#E0084
Imidazole (CU#1352) Tokyo Chemical Industry Cat#I0001
Hydroxyapatite (HAp) Sigma-Aldrich Cat#289396
RedDot 2 Biotium Cat#40061
Propidium iodide Life Technologies Cat#P21493
Agarose Nacalai Tesque Cat#01163-76
Silicon oil (RI = 1.555) Shin-Etsu Chemical Cat#HIVAC-F4
Mineral oil (RI = 1.467) Sigma-Aldrich Cat#M8410
CUBIC chemicals for screening Tokyo Chemical Industry Table S1
Critical Commercial Assays
LabAssay Phospholipid Wako Pure Chemical industries Cat#296-63801
LabAssay Cholesterol Wako Pure Chemical industries Cat#296-65801
Microplate BCA Protein Assay Kit-
Reducing Agent Compatible
Thermo Fisher Scientific Cat#23252
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hiroki R.
Ueda (uedah-tky@umin.ac.jp).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Marmoset
We studied an adult marmoset at the age of 12 months. Animal was maintained and handled in accordance with the recommenda-
tions of the United States National Institutes of Health, and all procedures were approved by the Animal Care and Use Committee of
the Graduate School of Medicine, Kyoto University, Japan.
Mice Model
For the chemical screening (Figures 1, 2, 3, 4 and S1, S2, S3 and Tables S1 and S2), the organs of adult mice (C57BL/6N, ICR, or
BALB/c-nu/nu) were used. The mice were sacrificed by an overdose of pentobarbital (> 100 mg/kg, Nacalai Tesque, 02095-04),
then transcardially perfused with 15 mL of PBS (pH 7.4) and 20 mL of 4% paraformaldehyde (PFA, Nacalai Tesque, 02890-45) in
PBS. Organs were dissected, then post-fixed with 4%PFA-PBS at 4C overnight. The fixed organs were then washed with PBS prior
to the experiments.
The Htr5b-tTA (Tanaka et al., 2012):tetO-YC (Kanemaru et al., 2014) (7 weeks old), Plp-tTA (Inamura et al., 2012):tetO-ChR2EYFP
(Tanaka et al., 2012) (10weeks old), Mlc-tTA (Tanaka et al., 2010):tetO-YC (11weeks old), Drd1-mVenus (Nagai et al., 2016) (7months
old), Th-EGFP (Matsushita et al., 2002) (6months old), Thy1-YFP-H (Feng et al., 2000) (6months old), and P(CAG)-EGFP (Okabe et al.,
1997) (8 weeks old) mouse strains were used to observe the expression patterns of fluorescently labeled cells in the brain.
P(CAG)::mRFP was transduced into mouse brain (8 weeks old) by in utero electroporation as described previously (Hayashi-Takagi
et al., 2015).
The human breast cancer cells, MDA-MB-231-5a-D (MDA-231-D), are a highly metastatic clone derived from MDA-MB-231
(Ehata et al., 2007). We established MDA-231-D cells that co-expressed luciferase and mCherry according to our recent
report (Kubota et al., 2017). To elicit experimental bone metastasis by intracardiac (i.c.) injection, MDA-231-D cells
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Experimental Models: Cell Lines
MDA-MB-231-5a-D Ehata et al., 2007 N/A
Experimental Models: Organisms/Strains
Htr5b-tTA:tetO-YC Tanaka et al., 2012 N/A
Kanemaru et al., 2014
Plp-tTA:tetO-ChR2EYFP Inamura et al., 2012 N/A
Tanaka et al., 2012
Mlc-tTA:tetO-YC Tanaka et al., 2010 N/A
DrD1-mVenus Nagai et al., 2016 N/A
Th-EGFP Matsushita et al., 2002 N/A
Thy1-YFP-H Feng et al., 2000 N/A
P(CAG)-EGFP Okabe et al., 1997 N/A
P(CAG)::mRFP Hayashi-Takagi et al., 2015 N/A
Software and Algorithms
Excel 2016 Microsoft N/A
Origin 7.0 OriginLab N/A
R R Core Team https://www.r-project.org
GraphPad Prism 5 GraphPad software N/A
ChemDraw Perkin Elmer N/A
Fiji Schindelin et al., 2012 https://fiji.sc/
Imaris Bitplane N/A
MATLAB Mathworks N/A
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(MDA-231-D: 13 105 cells/mouse) were injected into BALB/c-nu/nu mice (4-weeks old, female) by puncture into the left ventricle of
heart. Mice were sacrificed 4 or 5 weeks after injection.
All experimental procedures and housing conditions were approved by the Animal Care and the Use Committee of the Graduate
School of Medicine, University of Tokyo, and by the Animal Use and Care Committee of Niigata University, and all of the animals were
cared for and treated humanely in accordance with the Institutional Guidelines for Experiments using animals.
Human Tissue
Human tissues used for this study were obtained from 10 patients (59–90 years old; 9 males and 1 female). Written informed consent
for autopsy including the use of tissue for research purposes was obtained from the next of kin. Experiments using human tissues
were approved by the institutional review boards of Osaka University School of Medicine, Osaka, Japan, the Graduate School of




To comprehensively assess the ability of chemicals to solubilize lipids in a high-throughput manner, we used a previously reported
method (Susaki et al., 2014). In brief, 20 ml of homogenized mouse brain was mixed with 130 ml of each 10%(wt/wt) chemical solution
in 96-well plates and incubated at 37C overnight. After gentle shaking, the OD600 of the mixture was measured with a PowerWave
XS (Bio-Tek). The lipid solubility score was calculated as follows. First, the OD600 of each chemical solution alone was subtracted
from the OD600 of the mixture. The lipid solubility score was then determined by plotting the resulting OD600 on a line created by
assigning the OD600 of PBS-suspension as 0.0 and the OD600 of the chemical solution alone as 1.0. Among the non-detergent
and salt-free chemicals, those that were colored (OD600 R 0.1), of low solubility, or lacked a LogP value (octanol-water partition
coefficient) were excluded from the chemical profiling. To examine the relationship between tissue phospholipid or cholesterol con-
tent and transparency, adult mouse half brains were weighed and then immersed in various delipidating CUBIC chemicals (Figures
2E and S2D). After 1 day of delipidation at 37Cwith gentle shaking, the brains were washed with PBS at room temperature for a half
day with gentle shaking. The washed samples were then subjected to phospholipid or cholesterol quantification. To quantify the
phospholipid content, the samples were thoroughly crushed, then sonicated in 10% Triton X-100 in PBS to obtain a homogenized
suspension. After adjusting for the total weight of each sample, the phospholipid was quantified with LabAssay Phospholipid (Wako
Pure Chemical Industries, 296-63801) according to the instruction manual, with OD600. The absolute amount of phospholipid was
determined by fitting theOD600 value to a standard curve generated by a serially diluted pure phospholipid standard. The cholesterol
content was similarly quantified using LabAssay Cholesterol (Wako Pure Chemical Industries, 296-65801).
Tomeasure the relative transparency, delipidated samples were washed with PBS, and immersed inmodified ScaleCUBIC-2 [22.5
wt% antipyrine (Tokyo Chemical Industry, D1876), 22.5 wt% sucrose (Nacalai Tesque, 30403-55), 25 wt% urea (Nacalai Tesque,
35904-45), and 10 wt% triethanolamine (Wako Pure Chemical Industries, 145-05605)] overnight at room temperature with gentle
shaking. The transmittance was quantified with a Spectral Haze Meter SH 7000 (Nippon Denshoku Industries), as described in
our previous study (Tainaka et al., 2014).
After comprehensive screening for effective delipidation chemicals, we further assessed their delipidation ability when used in
combination with other chemicals, as shown in Figures 4A-4D, S3A and S3H. Adult mouse half brains, adult mouse kidneys, and hu-
man brain blocks were used to evaluate the chemicals’ delipidation ability. Each tissue was weighed prior to the experiment if
required for normalization. The mouse tissues were immersed in the cocktails for more than 1 day at 37C with gentle shaking, while
the human tissues were immersed in the cocktail for more than 4 days at 37C with gentle shaking. After delipidation, the samples
werewashedwith PBS overnight. If required to improve the transparency of the tissue, the samples were then subjected to RI-match-
ing procedures, consisting of 1:1-diluted CUBIC-R for one day followed by CUBIC-R for one more day. The washed samples were
then subjected to phospholipid quantification as described above.
Decoloring Ability
To comprehensively evaluate the decoloring ability of chemicals in a high-throughput manner, we used a previously reportedmethod
(Tainaka et al., 2014) with minor modifications. Because a large amount of blood was required for this screen, we used horse blood
(Kohjin-Bio, 12070110). Prior to screening, the blood was fixed in an equal volume of 8% PFA in PBS, and the mixture was then
diluted 4-fold with PBS. The fixation was performed at 37C for 16 hours. After removing clots by filtration, the sample was centri-
fuged at 1500 G for 3 minutes, and the supernatant was discarded. The pellet was washed with PBS. This centrifugation-washing
procedure was repeated for a total of three times. The final pellet was diluted in the same amount of PBS as the original volume
of blood. For the comprehensive screening, 50 ml of fixed blood and 150 ml of 10%(wt/wt) CUBIC chemical solution were mixed in
96-well plates. The samples were gently shaken for 1 day at 37C, then spun at 1500 G for 5 minutes, and 100 ml of the supernatant
was transferred to another 96-well plate. OD420 and OD700 were measured with an EnSpire plate reader (Perkin Elmer, USA). To
calculate the decoloring score, we first subtracted the OD700 from the OD420 to account for light scattering. The resulting value
was then divided by the value obtained for Quadrol. Among the non-detergent and salt-free chemicals, low-solubility chemicals
were excluded from the chemical profiling. After this comprehensive screening for decoloring chemicals, we used adult mouse
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spleen to examine the chemicals’ decolorization ability in biological tissues. An adult mouse spleen was immersed in 3 mL of the
CUBIC chemical solutions at 37C for 3 hours. Then, 100 ml of each supernatant was subjected to OD400 measurement. These re-
sults are summarized in Figure 2H.
RI Matching
To screen for chemicals with effective RI matching, we assumed that such chemicals would satisfy at least two conditions: colorless
with a high RI in 10%(wt/wt) solution, and highly soluble in water. To first identify chemicals with a high RI in 10%(wt/wt) solution,
we measured the OD400 with a PowerWave XS and the RI value of each CUBIC-chemical solution with an Abbe refractometer
(Atago, DR-A1, Japan) (Figures 3A and 3B). Next, we examined whether the chosen chemicals were soluble in water at 60-70 wt
%. The candidates satisfying these two criteria were then evaluated for their clearing performance in mouse lung. Prior to the RI-
matching step, the lungs were delipidated with ScaleCUBIC-1 for 2 weeks at 37C. For Figures 3C and 3E, the lungs were dissected
into small (3-5-mm) blocks, which were then immersed into 400 ml of 60-70wt%CUBIC chemical at room temperature overnight. The
resulting samples were transferred into 96-well plates, and the OD600 was measured with a PowerWave XS. For combinatorial
screening, the whole lungs were first immersed in 2 mL of the chemical cocktail diluted 1:1 with deionized water, then gently shaken
at room temperature overnight. The lungs were then immersed in 2 mL of the chemical cocktail with gentle shaking at room temper-
ature overnight. Pictures of the samples taken after RI matching are shown in Figures 4E and S3F.
Decalcification
Tomeasure the decalcifying ability of a chemical, we used a screen based on hydroxyapatite (HAp), a major component of bone, as a
surrogate for bone. Because the specific gravity of HAp (about 3.16) is much higher than that of water ( = 1), we dissolved 200 mg/ml
or 100 mg/ml HAp in 40%(v/v) glycerol to prevent its precipitation during the experiments. We then mixed 20 ml of homogenized HAp
solution with 130 ml of the 10%(wt/wt) chemical solutions in 96-well plates. After gentle shaking at 37C overnight, the plates were
centrifuged at 1500 G for 3 minutes, and the OD600 of the mixture was then measured with a PowerWave XS. The decalcification
score was calculated by plotting the resulting OD600 on a line in which the OD600 of PBS-HAp suspension was 0.0 and the
OD600 of EDTA-2Na-treated suspension (Figures 3F and 3I) or EDTA titrated with CU#0414-treated suspension (Figures 3H and
S2M) was 1.0.
Quenching of Fluorescent Proteins (FPs) by Chemicals
The pattern and expression level of FPs in tissue varies due to individual differences, making it difficult to accurately quantify the FP
quenching of chemicals, while an in vitro FP quenching assay is more quantitative and has higher reproducibility. Moreover, clearing
protocols usually involve some kind of chemical fixation (e.g., PFA, glutaraldehyde, or a Clarity-related embedding hydrogel), and the
FP signals can be dramatically affected by the fixation conditions (e.g., the fixative chemicals, concentration, duration, and temper-
ature). For these reasons, we conducted an in vitro FP quenching assay in this study.
To comprehensively measure the effect of CUBIC chemicals on the fluorescence intensity of fluorescent proteins (FPs), we used
EGFP and Sirius (Figures S1D and S1E). Recombinant EGFP at 0.05mg/ml and Sirius at 0.2 mg/ml were prepared in PBS. Then, 20 ml
of the FP solutions weremixed with 130 ml of each 10%(wt/wt) chemical solutions in 96-well plates. After gentle shaking at 37C over-
night, we measured the 507-nm emission for EGFP by 488-nm excitation, and the 427-nm emission for Sirius by 355-nm excitation,
with an EnSpire. A series of standard buffers with a pH range of 2-14was prepared, including 200mMglycine (pH 2.5, 3, 3.5, 12, 12.5,
and 13; Nacalai Tesque, 17109-35), 100 mM citrate (pH 4, 4.5, 5, 5.5, 6, 6.5, and 7; sodium citrate tribasic dehydrate, Sigma-Aldrich,
S4641), PBS (pH 7.5 and 8), 10mMborate (pH 8.5, 9, 9.5, and 10; borate reference solution, Horiba), 50mMNaHCO3 (pH 10.5 and 11;
Nacalai Tesque, 31212-25), and 100mMNaH2PO4 (pH 11.5; Nacalai Tesque, 31718-15). To further demonstrate the quenching effect
of each CUBIC protocol, we also used 16 mg/ml YFP and 15 mg/ml mCherry. The fluorescence intensities of these FPs were
measured as described above, using the appropriate excitation and emission wavelengths (Figures 4F and S3E).
pH evaluation
Because pH can significantly influence the chemical parameters in tissue clearing, we established a high-throughput pH measure-
ment assay using universal pH indicator paper (As One Corp., 1-1254-01). The papers were cut into circles and placed in the bottom
of 96-well plates, followed by the application of 2 ml of CUBIC chemicals. The absorbance at 550, 570, 610, and 660 nm was
measured with an EnSpire, then the pH was predicted according to a regression model.
To establish the regression model, we prepared a series of standard solutions with a pH range of 0-14: 200 mMKCl (pH 1, 1.5, and
2; Nacalai Tesque, 28514-75), 200mMglycine (pH 2.5, 3, 3.5, 12, 12.5, and 13; Nacalai Tesque, 17109-35), 100mMcitrate (pH 4, 4.5,
5, 5.5, 6, 6.5, and 7; sodium citrate tribasic dehydrate, Sigma-Aldrich, S4641), PBS (pH 7.5 and 8), 10 mM borate (pH 8.5, 9, 9.5, and
10; borate reference solution, Horiba), 50mMNaHCO3 (pH 10.5 and 11; Nacalai Tesque, 31212-25), and 100mMNaH2PO4 (pH 11.5;
Nacalai Tesque, 31718-15). The pH of the standard solutions was adjusted with hydrochloric acid or sodium hydroxide, and
measured with a benchtop pH meter (Horiba, LAQUA F-71). The predicted pH values were less accurate in the low (pH < 3) or
high (pH > 12) pH range by the single linear regression model. Therefore, we introduced three regression models: an acid-range,
a neutral-range, and a base-range regression model. The pH was first predicted with the neutral-range regression model. If the pre-
dicted pH was higher than 11.1, then the base-range regression model was applied. If the predicted pH was lower than 5.5, then the
acid-range regression model was applied. These thresholds were statistically determined by comparing themean square error of the
predicted pH and the measured pH.
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Concern about Potential False Negatives
Each chemical was used as a 10%(wt/wt) solution in all of the first chemical screenings. We hoped to minimize false negatives in the
first screening, so we would not miss potential candidates. Although chemicals were likely to have concentration-dependent effects
on each parameter, we could avoid false negatives by taking advantage of the chemical diversity of our chemical library. That is,
owing to our comprehensive chemical profiling, we could predict whether the performance of a chemical in the first screening
was under-estimated or not from its chemical structure.
We also considered the possibility of chemicals withmore dramatic concentration-dependent behavior. Concentration-dependent
self-aggregation of the solute is one of the most likely causes of dramatic concentration-dependent behavior. In aqueous medium,
hydrophobic chemicals precipitate and amphiphilic chemicals form micelles in a concentration-dependent manner. Since precipi-
tates would have no effect on tissue clearing, we focused on the ability of amphiphilic chemicals such as detergents to form
water-soluble micelles. To avoid false negatives in the amphiphilic chemicals, we prepared a wide variety of detergents, as shown
in Figure S2B. In this figure, we categorized a series of detergents according to the polarity head group, because each group of de-
tergents formsmicelles with similar chemical properties at concentrations above the critical micelle concentration (CMC). In general,
the CMC of a detergent tends to decrease as the hydrophobic part of the detergent molecule grows. Figure S2B indicates that the
micelle state exhibited much higher delipidation activity than the monomer state. This means that amphiphilic chemicals with a high
CMCwere potential false negatives in our delipidation screening. That is, the delipidation efficiency of these chemicals in vitromay be
much higher at concentrations above the CMC. However, micelle molecules are liable to have low permeability in real tissue as
described above, and higher solute concentrations often have a quenching effect on fluorescent proteins. Thus, we did not perform
additional experiments on the concentration dependence of such amphiphilic chemicals. In the decoloring screen, micelle molecules
had a similar tendency for low permeability as in real tissue (Figure 2H). For the RI matching and decalcification assays, we did not
observe significant positive outputs for amphiphilic chemicals.
Taken together, our chemical profiling approach applies chemical insights and hypotheses to tissue clearing, and these insights
are helpful for preventing potential false-negatives. Of course, our profiling is not perfect for false-negative detection due to unknown
chemical phenomena. Nevertheless, we are confident that our screening system has sufficient detection sensitivity without redun-
dancy and complexity to be useful for this field at the present time.
Comparison of Organic Solvents and Hydrophilic Chemicals
To examine the effects of organic solvents and hydrophilic chemicals, we included several organic solvents in this study, such as
tetrahydrofuran (THF, CU#1427), dimethyl sulfoxide (DMSO, CU#1510), 2-propanol (CU#1514), methanol (CU#1515), ethanol
(CU#1516), benzyl alcohol (CU#1517), benzyl benzoate (CU#1518), acetone (CU#1520), 1,4-dioxane (CU#1521), acetonitrile
(CU#1522), ethyl acetate (CU#1523), and N,N-dimethylformamide (DMF, CU#1524). However, we could not perform a comprehen-
sive evaluation of organic solvents due to experimental feasibility. First, almost all organic solvents (e.g., dichloromethane and di-
phenyl ether), with the exception of several alcohols and aprotic polar solvents, as listed, are immiscible with water. Second, plastic
experimental tools (e.g., microtubes and microplates) are highly labile to many organic solvents (especially at high concentration).
Therefore, we included only the above-listed organic solvents in this study. In our chemical screening, we prepared 10%(wt/wt)
aqueous mixtures of the organic solvents because of the above concerns and to make fair comparisons. However, these aqueous
mixtures displayed quite low performances (see Table S2); thus, organic solvents would exert their clearing performance at a high
concentration or in a fully dehydrated condition.
Chemical Parameters
To obtain a chemical profile for the chemicals identified from the screens, we analyzed a series of chemical parameters (e.g., LogP
and PSA) using the ChemOffice software. The LogP and LogS value of each chemical was calculated by the MOSES descriptor
Community edition (https://www.mn-am.com/services/mosesdescriptors). Solubility parameters (e.g., dD and dP) of each chemical
were calculated based on the Hansen solubility parameters (Hansen, 2007). The stability constant of various chemicals for Ca2+ ion
according to the NIST Standard Reference Database 46 was used (Smith et al., 2003).
Multivariate Linear Regression Analysis
We prepared a series of parameters consisting of three classes of parameters: functional parameters, solubility parameters
(calculated by Hansen solubility parameters), and structural and topological parameters (Figure S1F). The lists of parameters
used for delipidation, decolorization, and RI matching are shown in Figure 2C, S2I, and 3D, respectively. After normalizing the scores
and parameters, we performed partial least-squares (PLS) regression using four major PLS components. The variable importance in
projection (VIP) scores of two major PLS components were calculated from the results.
CUBIC Protocols
CUBIC Protocol I for Adult Mouse Organ Samples and Marmoset Brain
For the efficient clearing of mouse organs, we first performed an optional transcardiac perfusion of CUBIC-P reagents. After the
mouse was sacrificed by an overdose of pentobarbital, 15mL of PBSwas perfused followed by 20mL of 4%PFA-PBS. After another
15 mL of PBS was perfused, the transcardiac perfusion of 100 mL of CUBIC-P [mixture of 5 wt% 1-methylimidazole (Tokyo
Chemical Industry, M0508), 10 wt% CU#0414 (N-Butyldiethanolamine, Tokyo Chemical Industry, B0725) and 5 wt% Triton X-100
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(Nacalai Tesque, 12967-45)] from the left ventricle for 10 minutes was performed. After perfusion, the organs were dissected and
directly immersed in CUBIC-L (mixture of 10 wt% CU#0414 and 10 wt% Triton X-100). The organs in CUBIC-L were incubated
with shaking at 37C for 3-7 days. The immersion period was based on the sample size. If the immersion period was longer than
4 days, the CUBIC-L was refreshed at least once. After delipidation, the organs were washed in PBS with gentle shaking at room
temperature overnight. If required, the organs were stained with RedDot 2 (1:100, Biotium Inc, #40061) or propidium iodide
(10 mg/ml, PI; Life Technologies, P21493) in 0.1 M phosphate buffer (PB) containing 0.5 M NaCl with shaking at room temperature
for 3-5 days. The organs were then immersed in 1:1 water-diluted CUBIC-RA [recommended for FP-expressing organs, a mixture
of 45 wt% CU#0640 (antipyrine, Tokyo Chemical Industry, D1876) and 30 wt% CU#1283 (N-methylnicotinamide, Tokyo
Chemical Industry, M0374)] or in 1:1 water-diluted CUBIC-R [for other organs, mixture of 45 wt% CU#0640 and 30 wt%
CU#0855 (nicotinamide, Tokyo Chemical Industry, N0078)] with gentle shaking at room temperature for 1 day. The organs were
then immersed in CUBIC-RA or CUBIC-R with gentle shaking at room temperature for 1-2 days. The pH of CUBIC-R and CUBIC-
RA can be optionally adjusted to approximately 8-9with CU#0414. If required, the cleared organswere embedded in CUBIC-agarose
gel [2% agarose (Nacalai Tesque, 01163-76) dissolved in CUBIC-RA or CUBIC-R].
The clearing and staining of adult marmoset brain was performed as follows. The marmoset was sacrificed by an overdose of
pentobarbital (> 100 mg/kg, Nacalai Tesque, 02095-04), then transcardially perfused with 200 mL of cold PBS (pH 7.4) and
300 mL of 4% PFA-PBS. The brain was dissected, then post-fixed with 4% PFA-PBS at 4C overnight. After washing in PBS, the
brain was immersed in CUBIC-L with shaking at 37C for a total of 5 weeks, and then at 45C for 1 week. The CUBIC-L was refreshed
every 1-2 days throughout the delipidation. After washing in PBS, the brain was immersed in 10 mg/ml propidium iodide (PI) in PB
containing 1.5 M NaCl with shaking at 37C for a total of 19 days. The staining solution was refreshed after day 12. After washing
in PBS, the brain was immersed in 10 wt% imidazole (Tokyo Chemical Industry, I0001) aqueous solution with gentle shaking at
room temperature for 3 days. The imidazole solution was refreshed every day. The brain was then immersed in 1:1 water-diluted
CUBIC-R (pH adjusted to approximately 8-9 with CU#0414) with gentle shaking at room temperature for 3-4 days. Finally, the brain
was immersed in CUBIC-R (pH adjusted to approximately 8-9with CU#0414) with gentle shaking at room temperature for 7 days. The
CUBIC-R was refreshed after day 4.
CUBIC Protocol II for Mouse Body or Tissues That Include Bone
PFA-fixed samples were immersed in CUBIC-L with shaking at 37C for 3-7 days, then washed with PBS at room temperature over-
night. The immersion period was based on the sample size. If the immersion period was longer than 4 days, the CUBIC-L was re-
freshed at least once. The samples were immersed in CUBIC-B [10 wt% EDTA (Nacalai Tesque, 15105-35) and 15 wt% imidazole]
with shaking at 37C for 5-7 days, then washed with PBS at room temperature overnight. During decalcification, the CUBIC-B was
refreshed at least once. The samples were immersed in CUBIC-L with shaking at 37C for 2-4 days, then washed with PBS at room
temperature overnight. If required, the organs were stained with 10 mg/ml PI in 0.1 M PB containing 0.5 M NaCl with shaking at 37C
for 5-7 days. The samples were immersed in 1:1 diluted CUBIC-RA or CUBIC-R with gentle shaking at room temperature for 1 day.
The samples were then immersed in CUBIC-RA or CUBIC-R with gentle shaking at room temperature for 1-2 days. If required, the
cleared samples were embedded in CUBIC-agarose gel.
CUBIC Protocol III for Aggressive Tissue Clearing
Human tissues were stored in formalin at 4C until use. The dissected blocks were washed with PBS overnight prior to clearing. The
tissue blocks were immersed in CUBIC-HL [mixture of 10 wt% CU#0070 (1,3-bis(aminomethyl)cyclohexane, Tokyo Chemical Indus-
try, B1005) and 10 wt% CU#0631 (sodium dodecylbenzenesulfonate, Tokyo Chemical Industry, D0990), whose pH was adjusted to
12.0 by p-toluenesulfonic acid (Tokyo Chemical Industry, T0267)] with shaking at 37C (for human brain or kidney) or 45C (for human
heart, liver, lung, or spleen) for 1-2 weeks, then washed with PBS at room temperature. The immersion period was based on the sam-
ple size. Since the apparent opacity inside the sample gradually disappears as delipidation progresses, the delipidation period could
be easily judged by the appearance of the sample soaked in CUBIC-HL. Note that prolonged delipidation may damage the sample
morphology. If delipidation needs to be prolonged beyond 2 weeks, we recommend that the subsequent delipidation be done at a
lower temperature or in CUBIC-L. During delipidation, the CUBIC-HL should be refreshed at least once. If required, the organs were
stained with 10 mg/ml PI in 0.1MPB containing 0.5MNaCl with shaking at 37C for 5-7 days. After washing in PBS, the samples were
immersed in 1:1 diluted CUBIC-R with gentle shaking at room temperature for 1 day. The samples were then immersed in CUBIC-R
with gentle shaking at room temperature for 1-2 days. If required, the cleared organs were embedded in CUBIC-agarose gel.
CUBIC Protocol IV for Large Blocks of Human Brain Tissue
Human brain blocks were stored in phosphate-buffered formalin at 4C until use. The dissected blocks (around 1 cm3) were washed
with PBS overnight prior to clearing. The brain blocks were immersed in CUBIC-L with shaking at 45C for 1-2 weeks, then washed
with PBS at room temperature. The immersion period was based on the volume of white matter. During delipidation, the CUBIC-L
was refreshed at least once. After washing in PBS, the samples were immersed in 1:1 diluted CUBIC-R with gentle shaking at
room temperature for 1 day. The samples were then immersed in CUBIC-R with gentle shaking at room temperature for 1-2 days.
We noted that the autofluorescence of cerebral cells decreased as the delipidation period increased. We recommend that delipida-
tion be finished by approximately one week to preserve sufficient autofluorescent signals. If required, the cleared samples were
embedded in CUBIC-agarose gel.
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Deformation Analysis of Cleared Brains
Brains after PBS, CUBIC protocol I without pH adjustment, and CUBIC protocol I with pH adjustment to 8-9 were subjected to defor-
mation analysis. Two brains were prepared for each procedure, and then projection images were captured by a ChemiDoc XRS Plus
(Bio-Rad). The brains were manually segmented, then registered to a standard post-fixed brain. The average of the two obtained
deformation fields was visualized and mapped onto a representative projection image of the brain.
Long-term Tissue Preservation
To preserve the cleared tissue for a long time, we recommend storing it in O.C.T. compound at 80C after washing it with PBS as
described in our previous paper (Susaki et al., 2015). In this storagemedium, FP signals can be preserved for several months to years.
Immunostaining
For Figure 5D, an 8-week-old ICR mouse brain was washed with PBS after 4 days of delipidation with CUBIC-HL. The brain was
immersed in 40% sucrose for 1 day, embedded in O.C.T. compound (Sakura Finetek), and sectioned with a cryostat (CM3050S,
Leica). The brain sections were immersed in 200 ml of PBST with 1% anti-GFAP-Cy3 (C9205, Sigma-Aldrich) or 0.1% anti-NeuN
(MAB377, Millipore) antibodies. For NeuN detection, a secondary antibody (A21203, Thermo Fisher Scientific) was applied. For
Figure 5F, the human brain was washed with PBS overnight and sliced after 9 days of delipidation with CUBIC-L (CUBIC protocol
IV). The slice was placed into 400 ml of immunostaining buffer (mixture of PBS, 0.5% Triton X-100, 0.25% casein, and 0.01%
NaN3) containing 1:20 diluted rhodamine-conjugated lectin (RL-1062, Vector Laboratories) or 1:10 diluted Alexa647-conjugated
a-SMA (alpha smooth muscle actin) antibody (IC1420R, Novus Biologicals) for 5 days at room temperature with gentle shaking.
For the control experiment, the immunostaining buffer without antibody was applied. After washing the samples with PBS for several
hours, the samples were immersed into CUBIC-R according to CUBIC protocol IV.
Microscopy
Light-sheet Fluorescence Microscopy (LSFM)
Macroscopic whole-body or organ images were acquired with two custom-built LSF microscopes (MVX10-LS, developed by
Olympus). Images were captured using a 0.63 3 objective lens [numerical aperture (NA) = 0.15, working distance = 87 mm] with
digital zoom from 1 3 to 6.3 3 . The first LSF microscope was equipped with lasers emitting at 488 nm, 532 nm, 590 nm, and
639 nm. The second was equipped with lasers emitting at 488 nm, 532 nm, 594 nm, and 637 nm. When the stage was moved to
the axial direction, the detection objective lens was synchronically moved to the axial direction to avoid defocusing. The RI-matched
sample was immersed in an oil mixture (RI = 1.525) composed of silicon oil HIVAC-F4 (RI = 1.555, Shin-Etsu Chemical) andmineral oil
(RI = 1.467, M8410, Sigma-Aldrich) during image acquisition.
A customized light-sheet microscope was used for the high-resolution-imaging of the organs of adult mice in Figure S5. Fluores-
cence excited by a 488 nmCW laser (Omicron, SOLE-3) was captured with a sCMOS censor (Andor, Neo) using a 103 objective lens
(XLPLN10XSVMP, NA = 0.6, working distance = 8mm, Olympus). The details of the light-sheet microscope are described in our pre-
vious study (Murakami et al., 2018). To obtain complete views, the regions of interest were divided into 73 4 tiles (for the left medial
lobe of themouse liver), or 63 8 tiles (for the left lung of themouse). Images were collected by scanning the sample in the z-direction,
with a step size of 5 mm.
Confocal Microscopy
An upright confocal microscope (FV1200, Olympus) was used for microscopic 3D imaging. The microscope was equipped with a
25 3 objective lens (XLSLPLN25XGMP, NA = 1.0, WD = 8.0 mm, Olympus). A 473 nm laser was used for image acquisition. During
image acquisition, RI-matched samples were immersed in a mixture of silicon oil (RI = 1.525) as described above.
In Vivo Bioluminescence Imaging
Mice were anesthetized with avertin, and D-luciferin potassium salt (Promega) was injected intraperitoneally. Ten to fifteen minutes
after injection, the luciferase activity was measured using a NightOWL II LB983 (Berthold Technologies GmbH & Co. KG, Bad
Wildbad, Germany).
Histological Examination
After CUBIC-based clearing, biological samples were washed with PBS, embedded in paraffin, and subjected to HE staining as pre-
viously described (Hoshino et al., 2015) and to a series of immunostainings (Figures 5E and S6I).
Image Analysis
The Analysis of Cellular Nuclei
The cellular nuclei in organs were comprehensively detected by our image-processing pipeline (Murakami et al., 2018). The process
can be divided into two steps: 2D detection of cells and 3D unification of multiply detected cells. The 2D detection of cells was per-
formed by detecting local maxima after applying a mean filter to raw images. Then, 3D local maxima were detected after a 3D mean
filter was applied to the 2D-detected cells. The detected cellular nuclei (‘‘points’’ or ‘‘point clouds’’) were further analyzed for the seg-
mentation of tubular structures. To this end, we used the alpha shape function with the specific alpha radius by using MATLAB. The
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alpha radius was set at 30 mm for liver and 50 mm for lung. After forming the alpha shape, the surface points composing the alpha
shape were used. Since the surface points also included cells located in the outer layer of the organ, we removed those points by
applying a manually generated mask. The points are shown in red or magenta in Figures S5J and S5L.
Multi-directional Image Fusion
For Figures 6, 7, S5 and S6, multi-directional image fusion was performed after the acquisition of images from multiple directions
unless noted. All the samples were embedded in agarose, and mounted in the LSF microscope. We first performed the imaging
with both optical arms of the LSF microscope (i.e., left and right) from one direction (top-to-bottom). The samples were then flipped
180 manually, followed by image acquisition (bottom-to-top) with both optical arms. The imaging sequences were then repeated for
multi-color imaging. These processes produced four stacks per channel: a right-side-illuminated top-bottom stack (TB-R), left-side-
illuminated top-bottom stack (TB-L), right-side-illuminated bottom-top stack (BT-R), and left-side-illuminated bottom-top stack
(BT-L). For the registration process, we set the TB-L stack as the fixed images, then three other stacks were registered to TB-L stack.
Prior to registration, the stacks were reduced to less than 4GB by croppingmarginal regions, or by downsampling them into isotropic
voxel sizes to reduce the computational cost. Then, TB-R and BT-L were directly registered onto TB-L with an affine transformation
using ANTs (Avants et al., 2011). Because the direct registration of BT-R to TB-L often ends in misalignment due to the intensity gaps
of these two stacks, we performed indirect registration by registering BT-R onto BT-L, followed by the application of the affine matrix
obtained from the registration of BT-L onto TB-L. These mutually registered images were fused using the Fiji software, Multiview
Reconstruction (Schindelin et al., 2012).
Segmentation
For segmentation of the mouse kidney glomeruli in Figure S5, we used HLoG (Hessian based Difference of Gaussian) developed by
Zhang et al. (Zhang et al., 2015) with minor modifications. In the original paper, renal glomeruli were extracted by unsupervised clus-
tering. Because this method was originally optimized for MRI-scanned images and therefore could not show high accuracy, we intro-
duced a manual threshold for the smallest eigenvalue to achieve higher accuracy.
For the segmentations of metastatic cancer in Figures 6H and 7H, the thresholds were applied based on absolute intensity. Manual
segmentation was performed to segment the human kidney glomeruli (Figures 6J and 6K).
Virtual Multiplex Fluorescence Imaging and Analysis of Whole Brain
Fluorescently labeled mouse brains were stained with a far-red nuclear stain, RedDot 2, prior to the RI-matching process. The
cleared brains were embedded in agarose gel as mentioned above. Brain images were captured using a 0.63 3 objective lens
with a 1.253 zoom. The brain structures were visualized by the RedDot 2 fluorescent signal at 637-nm excitation. The sectional im-
ages were taken at 7.5-mm steps from both the right and left sides with a fixed focal position of the light sheet. The FP signal was then
visualized using a laser of appropriate wavelength with sequential shifting of the focal position of the light sheet. The thinnest focal
point of the LSF microscope was horizontally scanned 6 times per plane to reduce defocus derived from the Gaussian shape of the
beam. The scanning with focus shifts was performed from both sides of the illumination arm as described previously (Gao, 2015;
Santi et al., 2009).
The images of the identical horizontal positions (2 images for RedDot 2 signal, or 12 images for FP signals) were fused using the
content-based fusion algorithm proposed by Preibisch et al. (Preibisch et al., 2009). To register individual brains, the fused volumetric
nucleus images were downsampled 5:1 in one direction. These downsampled images were registered using the ANTs software in the
symmetric normalization (SyN) manner. The obtained transformation information was applied to the original volumetric FP images,
thus achieving registration without losing the resolution. To apply the transformation information to large data, we used our custom-
ized MATLAB code, because direct application of the transformation with the default algorithm in ANTs requires a huge amount of
memory, which makes it practically impossible. The overall process (fusion, registration, application of transformation information)
was fully automated.
Volume Rendering and Image Visualization
To generate the tubular structures shown in Figures S5K and S5M, visual mapping of the alpha shape was implemented byMATLAB.
For other volume rendered images, Imaris software (version 8.1.2, Bitplane) was used. The section images were generated by Imaris
or Fiji software.
QUANTIFICATION AND STATISTICAL ANALYSIS
Protein Quantification
Human brain tissue was weighed and then immersed in PBS, ScaleCUBIC-1, CUBIC-L, or CUBIC-HL. After 4 days of delipidation at
45C with gentle shaking, the brain samples were washed with PBS at room temperature for half a day with gentle shaking. The
washed samples were then subjected to protein quantification. To quantify the residual protein content, the samples were thoroughly
crushed, then sonicated in 1% Triton X-100 in PBS to obtain a homogenized suspension. After adjusting for the total weight of each
sample, the protein was quantified with the Microplate BCA Protein Assay Kit-Reducing Agent Compatible (ThermoScientific,
#23252) according to the instruction manual, with OD570. The absolute amount of protein was determined by fitting the OD570 value
to a standard curve generated by a serially diluted pure Albumin standard.
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Quantification of Image Quality
We used discrete cosine transformation Shannon entropy (DCTS) (Royer et al., 2016) to quantify the image quality. The DCTS calcu-
lation was performed for every plane image in Figure S5B, and for every 10 plane images in Figures S5H and S5I.
Statistical Analysis
Statistical analyses were performed by R version 3.1.0. and Origin 2016 (OriginLab, Northampton, MA, USA).
For the chemical profiling involving functional analysis and pH dependency (Figures 2A, 2B, 2G, 3A, 3F, S1E, and S2H), normality
was evaluated by the Kolmogorov-Smirnov test with a significance level of 0.05. These analyses showed that not all members of the
group were normal. The chemical functional group and pH dependency were compared to the control (alcohol group and pH 7-8,
respectively) by the Steel test.
For the other chemical analyses, normality was evaluated by the Kolmogorov-Smirnov test with a significance level of 0.05. When
all of the members of the group were normal, the homogeneous variance for each group was evaluated by Bartlett’s test with a sig-
nificance level of 0.05. When all of the groups were normal distributions with equal variance, the Turkey-Kramer test was used, when
the groups were normal distributions without equal variance, the Games-Howell test was used, and otherwise the Steel-Dwass test
was applied. In this study, p < 0.05 was considered as significant (*p < 0.05, **p < 0.01, ***p < 0.001, and n.s. for not significant
evaluations).
DATA AND SOFTWARE AVAILABILITY
Our customized MATLAB codes used for the virtual multiplex fluorescence imaging and analysis are publicly available at https://
github.com/DSP-sleep/Landscape_pipeline. The other computer codes used in this study are available upon request.
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